gamer456148

Decent Dip Entry for CAPR: Buy Alert!

做多
NASDAQ:CAPR   Capricor Therapeutics, Inc.
Right now, I am confident enough to say that CAPR is due for a likely reentry. I believe that it has been recently oversold and the bearish correlation is about to have its resistance popped quite soon. The upswing potential is there. That being said, please proceed with caution and invest at your own risk. As always, everything I say is on an opinion based basis not meant to be taken seriously as actionable financial advice. Do your own due diligence.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。